Estimating the Value of New Technologies That Provide More Accurate Drug Adherence Information to Providers for Their Patients with Schizophrenia

BACKGROUND: Nonadherence to antipsychotic medication among patients with schizophrenia results in poor symptom management and increased health care and other costs. Despite its health impact, medication adherence remains difficult to accurately assess. New technologies offer the possibility of real-...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafrin, Jason, Schwartz, Taylor T., Lakdawalla, Darius N., Forma, Felicia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397938/
https://www.ncbi.nlm.nih.gov/pubmed/27783545
http://dx.doi.org/10.18553/jmcp.2016.22.11.1285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397938/
https://www.ncbi.nlm.nih.gov/pubmed/27783545
http://dx.doi.org/10.18553/jmcp.2016.22.11.1285

Ejemplares similares